Skip to main content
Clinical Trials/IRCT201303287373N4
IRCT201303287373N4CompletedPhase 2

The efficacy of anti – toxoplasma drugs in the treatment of schizophrenia , a triple – blind, randomized , placebo-controlled clinical trial

Arak University of Medical Sciences0 sites200 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 55 years (—)
Sex
All

Inclusion Criteria

  • Inclusion criteria :informed written consent ;diagnosis of schizophrenia according to DSMIV _TR criteria and clinical interview by psychiatrist ;a score of at least 60 in PANSS;age range 15-55
  • Exclusion criteria: pregnancy ; lactation ;substance abuse; severe physical disease ; contraindication of cotrimoxazole

Exclusion Criteria

  • Not provided

Investigators

Similar Trials